Development of a bio-relevant dissolution test device simulating mechanical aspects present in the fed stomach.

A novel bio-relevant in vitro dissolution device was designed to mimic intragastric conditions after food intake paying particular consideration to mechanical aspects: the Fed Stomach Model (FSM). The FSM represents a fully computer-controlled dynamic flow-through system, in which dosage forms are hosted in so-called gastric vessels. Dosage form movement profiles as well as pressures can be simulated in a physiologically relevant manner. This proof-of-concept study aimed at the investigation of the effects of individual parameters and complex test programs on the drug delivery behavior of diclofenac sodium bilayer extended release tablets. Magnetic marker monitoring experiments demonstrated the applicability of the FSM to simulate intragastric movement velocities of solid oral dosage forms equivalent to in vivo data. Dissolution experiments revealed the relevance of all simulated parameters (i.e. pressure, dosage form movement and pump rate). Moreover, three different test scenarios with test programs specific for fundus, antrum and gastric emptying considered the variability of intragastric transit of solid oral dosage forms after food intake and were confirmed to be reasonable. Dissolution rates were low under conditions specific for fundus owing to low shear stresses. In contrast, higher amounts of the drug were released under high stress conditions simulating antral transit and gastric emptying. Concluding, the FSM can be a valuable tool for bio-relevant dissolution testing due to its potential of precise and reproducible simulation of mechanical parameters characteristic for the fed stomach.

[1]  W. Chey,et al.  The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology , 2009, Alimentary pharmacology & therapeutics.

[2]  Khoa Tran,et al.  Evaluation of regional and whole gut motility using the wireless motility capsule: relevance in clinical practice , 2012, Therapeutic advances in gastroenterology.

[3]  J. Slavin,et al.  Feasibility of measuring gastric emptying time, with a wireless motility device, after subjects consume fiber-matched liquid and solid breakfasts , 2011, Appetite.

[4]  Bertil Abrahamsson,et al.  Comparison of dissolution profiles obtained from nifedipine extended release once a day products using different dissolution test apparatuses. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[5]  J. Brasseur,et al.  A Novel in Vitro and Numerical Analysis of Shear-Induced Drug Release from Extended-Release Tablets in the Fed Stomach , 2005, Pharmaceutical Research.

[6]  P Boesiger,et al.  Pressure-geometry relationship in the antroduodenal region in humans. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[7]  Allan Geliebter,et al.  Gastric capacity in normal, obese, and bulimic women , 2001, Physiology & Behavior.

[8]  Gowland,et al.  Fat delays emptying but increases forward and backward antral flow as assessed by flow‐sensitive magnetic resonance imaging , 1999, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[9]  R. Fisher,et al.  Gastric emptying of a non‐digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy , 2008, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[10]  M. Wickham,et al.  The Design, Operation, and Application of a Dynamic Gastric Model , 2012 .

[11]  Clive G. Wilson,et al.  In vivo imaging of drug delivery systems in the gastrointestinal tract. , 2011, International journal of pharmaceutics.

[12]  W. Weitschies,et al.  A biorelevant dissolution stress test device – background and experiences , 2010, Expert opinion on drug delivery.

[13]  J. Dressman,et al.  Upper Gastrointestinal (GI) pH in Young, Healthy Men and Women , 1990, Pharmaceutical Research.

[14]  W. Weitschies,et al.  Simulating the postprandial stomach: physiological considerations for dissolution and release testing. , 2013, Molecular pharmaceutics.

[15]  B. Abrahamsson,et al.  Food effects on tablet disintegration. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[16]  M. Camilleri Integrated upper gastrointestinal response to food intake. , 2006, Gastroenterology.

[17]  R. Singh,et al.  Disintegration of solid foods in human stomach. , 2008, Journal of food science.

[18]  M. Fox,et al.  Magnetic resonance imaging for the assessment of gastrointestinal function , 2006, Scandinavian journal of gastroenterology.

[19]  J. Sjögren,et al.  Investigation of prandial effects on hydrophilic matrix tablets. , 1999, Drug development and industrial pharmacy.

[20]  D. Barrett,et al.  Drug release from HPMC matrices in milk and fat-rich emulsions. , 2011, Journal of pharmaceutical sciences.

[21]  Lutz Trahms,et al.  Impact of the intragastric location of extended release tablets on food interactions. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[22]  M. Ferrua,et al.  Modeling the Fluid Dynamics in a Human Stomach to Gain Insight of Food Digestion , 2010, Journal of food science.

[23]  P. Boesiger,et al.  Quantification of distal antral contractile motility in healthy human stomach with magnetic resonance imaging , 2006, Journal of magnetic resonance imaging : JMRI.

[24]  J. Malagelada,et al.  Measurement of gastric functions during digestion of ordinary solid meals in man. , 1976, Gastroenterology.

[25]  W. Weitschies,et al.  Simulating the postprandial stomach: biorelevant test methods for the estimation of intragastric drug dissolution. , 2013, Molecular pharmaceutics.

[26]  L. Trahms,et al.  Magnetic marker monitoring of esophageal, gastric and duodenal transit of non-disintegrating capsules. , 1999, Die Pharmazie.

[27]  L. Trahms,et al.  Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[28]  Clive G. Wilson,et al.  Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[29]  D. Menne,et al.  Measuring the interaction of meal and gastric secretion: a combined quantitative magnetic resonance imaging and pharmacokinetic modeling approach , 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[30]  Susan A. Barker,et al.  Achieving Antral Grinding Forces in Biorelevant In Vitro Models: Comparing the USP Dissolution Apparatus II and the Dynamic Gastric Model with Human In Vivo Data , 2011, AAPS PharmSciTech.

[31]  K. Schulze Imaging and modelling of digestion in the stomach and the duodenum , 2006, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[32]  James G Brasseur,et al.  Gastric flow and mixing studied using computer simulation , 2004, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[33]  Mark McAllister,et al.  Dynamic dissolution: a step closer to predictive dissolution testing? , 2010, Molecular pharmaceutics.